Geron Corporation (0IV3.L) Stock Price
$1.48 3%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Geron Corporation, AI stock picks, stock alerts and much more.
0IV3.L AI Stock Analysis
AI stock analysis for 0IV3.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron Corporation (0IV3.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Geron Corporation (0IV3.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron Corporation (0IV3.L), currently trading at $1.48, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0IV3.L
-
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
-
Symbol
0IV3.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
941.1M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$392.3 0.6% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$133.4 0.7% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.88 1% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.86 4.9% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11.98 0.7% |
5 |
News
0IV3.L Alternative Data
Web Traffic
Geron Corporation receives an estimated 12118 monthly visitors to geron.com.
-
Web Traffic
12118
-
Change from Previous Month
6.6%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Job Postings
Geron Corporation has an estimated 11 open job postings, which is down -47.6% over the last month.
-
Job Postings
11
-
Daily Change
0%
-
1 Month Change
47.6%
-
3 Month Change
66.7%
-
YoY Change
66.7%
Reddit Mentions
Geron Corporation has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
20,223 are following Geron Corporation on LinkedIn, up by 5.1% over the last month.
-
LinkedIn Followers
20223
-
Daily Change
5.1%
-
1 Month Change
5.1%
-
3 Month Change
17.1%
-
YoY Change
17.1%
LinkedIn Employees
According to LinkedIn, Geron Corporation has 405 employees, up by 2.5% over the last month.
-
LinkedIn Employees
405
-
Daily Change
2.5%
-
1 Month Change
2.5%
-
3 Month Change
4.7%
-
YoY Change
4.7%
Business Outlook
According to employee reviews, the business outlook among employees at Geron Corporation is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Geron Corporation was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0IV3.L Financials
0IV3.L Key Metrics
-
Total Revenue
$39.6M
-
Net Income
-$19.8M
-
Earnings per Share
-$0.03
-
Free cash flow
-$48M
-
EBITDA
-$16.7M
-
EBITDA Ratio
-0.421786
-
Total Assets
$562.5M
0IV3.L 2-year Revenue & Income
0IV3.L 2-year Free Cash Flow
0IV3.L Technicals
0IV3.L SMA
0IV3.L RSI
FAQ
What's the current price of Geron Corporation (0IV3.L) Stock?
The price of an Geron Corporation (0IV3.L) share is $1.48.
What's the market cap of Geron Corporation?
The current market cap of Geron Corporation is 941.1M.
Should I buy or sell 0IV3.L?
Geron Corporation shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Geron Corporation is better viewed as a hold or accumulate position while waiting for further developments.
Is Geron Corporation a good investment?
The current analysis of Geron Corporation's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Geron Corporation's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Geron Corporation (0IV3.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Geron Corporation stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Geron Corporation (0IV3.L) that investors often compare it to?
Geron Corporation (0IV3.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Geron Corporation's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron Corporation's stock price to be around $1.49 in 2026. Starting from the current price of $1.48, this represents a 1.2% change in price, indicating a neutral outlook for the stock.
How to buy Geron Corporation (0IV3.L) Stock?
Geron Corporation stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron Corporation shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.